Stock Under $10 with 50-100% upside potential - 14 Days FREE!

4 Health Care Stocks Under $10 Spiking Higher

Stock quotes in this article: ARNA, ITMN, PGNX, CHTP 

Chelsea Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Chelsea Therapeutics (CHTP) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products. This stock is trading up 3.8% to $1.34 in recent trading.

Today's Range: $1.29-$1.38

52-Week Range: $0.70-$5.74

Volume: 520,000

Three-Month Average Volume: 461,855

>>5 Stocks With Big Insider Buying

From a technical perspective, CHTP is moving notably higher here with above-average volume. This move is quickly pushing CHTP within range of triggering a near-term breakout trade. That trade will hit once CHTP manages to take out some near-term overhead resistance levels at $1.39 to $1.48, and then once it clears $1.54 with high volume.

Traders should now look for long-biased trades in CHTP as long as it's trending above $1.29, and then once it sustains a move or close above those breakout levels with volume that hits near or above 461,855 shares. If that breakout triggers soon, then CHTP will setup to re-test or possibly take out its nest major overhead resistance levels at $1.83 to $1.99, or possibly even its 200-day moving average at $2.24.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,346.07 -8.33 -0.05%
NASDAQ 3,497.00 -1.97 -0.06%
S&P 500 1,667.24 -0.23 -0.01%
US 10 Yr 1.965% +0.016

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs